Founder & CEO
Jon has more than 15 years’ experience in the Healthcare, CRO and Pharmaceutical industries. Holding leadership positions in both Clinical Operations and Clinical Finance roles.
Formerly Therapeutic Area Head for Oncology at MSD, he led both the Clinical Research Manager and Finance Clinical Operations Manager teams, responsible for the strategic implementation and delivery of a portfolio of clinical trials within the UK and Ireland.
As well as working in the Pharma/Biotech industry, Jon has also held roles in ICON, the NHS and the National Institute for Health Research, giving a unique insight into the challenges of trial delivery. Jon co-founded nmible in order to address some of these challenges.
Non-Executive Director
Graeme was recently Chief Technology Officer for a tech start up developing software products for Life Sciences. He assisted growth through acquiring three US-based tech companies leading to its ultimate acquisition. Owning the product vision & roadmap, he steered the analysis& development teams and forged strong relationships within US and global pharmaceutical clients.
Previously, Graeme designed and developed financial software, managed technology teams & departments, and provided advisory and delivery consultancy to central government, NHS and Microsoft. His technology career began with a degree and PhD in Computer Science from the Queen’s University of Belfast.
Graeme currently focusses on three non-executive roles as well as his passions for screenwriting, Leeds United and Ulster Rugby.
Non-Executive Director
Seb has over 25 years of experience in finance, both in the public and private markets. He currently holds the position of Chief Financial and Operations Officer at Mirada Medical and previously has held leadership positions at Induction Healthcare PLC, DrugDev Inc and IQVIA.
During Seb’s time at DrugDev Inc, he was part of the team that executed a buy and build strategy in the clinical trials technology market which led Seb to his role at IQVIA.
With his extensive financial background and his work in the clinical trials technology space, Seb is an invaluable addition to our nmible team and will support us to reach our plans as we grow.